Durvalumab: Ph Ib started

OncoPep Inc. (North Andover, Mass.) said investigators began an open-label, U.S. Phase Ib trial to evaluate intramuscular PVX-410 plus IV durvalumab in about 20 patients. Patients will receive PVX-410...